We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$42.5B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+5.34%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$43.1B
AUM Growth
+$1.45B
(+3.5%)
Cap. Flow
-$96.7M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
45.82%
Holding
319
New
11
Increased
71
Reduced
116
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$194M |
| 2 |
NVIDIA
NVDA
|
+$146M |
| 3 |
UnitedHealth
UNH
|
+$137M |
| 4 |
Meta Platforms (Facebook)
META
|
+$117M |
| 5 |
Philip Morris
PM
|
+$68.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$184M |
| 2 |
HES
Hess
HES
|
+$175M |
| 3 |
Nike
NKE
|
+$95.7M |
| 4 |
PepsiCo
PEP
|
+$94.4M |
| 5 |
Apple
AAPL
|
+$83.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.75% |
| 2 | Financials | 18.34% |
| 3 | Consumer Staples | 10.86% |
| 4 | Healthcare | 8.86% |
| 5 | Communication Services | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
iShares Core S&P 500 ETF
IVV
$843B
| $559K | ﹤0.01% |
835
-6
| -0.7% | -$3.86K |
|
227
Selective Insurance
SIGI
$5.33B
| $555K | ﹤0.01% |
+6,846
| New | +$552K |
|
228
Halozyme
HALO
$12.3B
| $550K | ﹤0.01% |
7,500
| – | – |
|
229
Palantir
PLTR
$416B
| $545K | ﹤0.01% |
2,988
| – | – |
|
230
Prosperity Bancshares
PB
$8.59B
| $543K | ﹤0.01% |
8,188
| – | – |
|
231
Capital One
COF
$127B
| $537K | ﹤0.01% |
2,528
-103
| -4% | -$22.5K |
|
232
CVS Health
CVS
$122B
| $521K | ﹤0.01% |
6,913
+140
| +2% | +$9.6K |
|
233
Boston Scientific
BSX
$65.3B
| $520K | ﹤0.01% |
5,327
+111
| +2% | +$11.5K |
|
234
Verizon
VZ
$213B
| $513K | ﹤0.01% |
11,680
+110
| +1% | +$4.76K |
|
235
Carlisle Companies
CSL
$13.3B
| $508K | ﹤0.01% |
1,545
| – | – |
|
236
Alcon
ALC
$32.7B
| $500K | ﹤0.01% |
+6,709
| New | +$560K |
|
237
CrowdStrike
CRWD
$241B
| $490K | ﹤0.01% |
4,000
| – | – |
|
238
Manulife Financial
MFC
$72.1B
| $486K | ﹤0.01% |
15,593
| – | – |
|
239
News Corp Class A
NWSA
$15.8B
| $483K | ﹤0.01% |
15,714
| – | – |
|
240
United Rentals
URI
$61.6B
| $477K | ﹤0.01% |
500
| – | – |
|
241
Ball Corp
BALL
$15.9B
| $474K | ﹤0.01% |
9,400
| – | – |
|
242
Archer Daniels Midland
ADM
$41.7B
| $466K | ﹤0.01% |
7,800
| – | – |
|
243
T-Mobile US
TMUS
$196B
| $466K | ﹤0.01% |
1,945
| – | – |
|
244
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.65B
| $457K | ﹤0.01% |
3,526
| – | – |
|
245
Cintas
CTAS
$80.6B
| $455K | ﹤0.01% |
2,216
-72
| -3% | -$15.4K |
|
246
Campbell Soup
CPB
$6.34B
| $442K | ﹤0.01% |
14,000
-1,100
| -7% | -$35.6K |
|
247
Powell Industries
POWL
$6.22B
| $442K | ﹤0.01% |
4,350
| – | – |
|
248
Tractor Supply
TSCO
$17.6B
| $435K | ﹤0.01% |
7,655
| – | – |
|
249
Parker-Hannifin
PH
$120B
| $434K | ﹤0.01% |
573
+23
| +4% | +$17K |
|
250
Carlyle Group
CG
$15.1B
| $429K | ﹤0.01% |
6,849
| – | – |
|
Similar funds
PCH
GAM
Fayez Sarofim & Co's Q3 2025 Portfolio in Review
As of Q3 2025, Fayez Sarofim & Co held 319 positions worth $43.1B, up 3.5% from $41.7B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Fayez Sarofim & Co's Q3 2025 filing shows 11 new, 71 increased, 116 reduced and 14 closed positions. Its largest new stake was SAP: 49,674 shares worth $13.3M. The largest sale was Novo Nordisk, an estimated $184M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Staples.
- Fayez Sarofim & Co's largest Q3 2025 buy was SAP: 49,674 shares worth $13.3M.
- Fayez Sarofim & Co added most to Chevron in Q3 2025, an estimated $194M increase.
- Fayez Sarofim & Co's biggest Q3 2025 reduction was Novo Nordisk, cutting an estimated $184M.
- Fayez Sarofim & Co fully exited Hess in Q3 2025, selling an estimated $175M.
- Fayez Sarofim & Co's ten largest holdings make up 46% of its $43.1B portfolio in Q3 2025.
- Fayez Sarofim & Co opened 11 new positions and closed 14 in Q3 2025.
- Fayez Sarofim & Co's portfolio value rose 3.5% quarter-over-quarter to $43.1B.
Based on Fayez Sarofim & Co's 13F filing for Q3 2025, filed 14 Nov 2025.